Agency Forms Undergoing Paperwork Reduction Act Review, 28817-28819 [2019-13053]
Download as PDF
<![CDATA[
28817
Federal Register / Vol. 84, No. 119 / Thursday, June 20, 2019 / Notices
TABLE 1—EXPLANATION OF DURATION AND FREQUENCY OF HEMODIALYSIS UNDER CONSIDERATION FOR KQS 1–3—
Continued
Duration (hours per session)
Less than 4 hours
4 or more sessions .......................
4 hours and more
9- to <16** hours per week ..........
>=16 hours per week
* Usual care involves 3 sessions per week with 3–4 hours per session.
** The duration of each dialysis session is generally shorter when dialysis is done more frequently.
Key Question 4
What instruments have been used to
measure QOL in studies of people with
ESRD treated by dialysis?
Subquestion 4a: What are the
psychometric properties of instruments
used to measure QOL in studies of
people with ESRD treated by dialysis?
Subquestion 4b: What is the minimal
clinically important difference for
instruments used to measure QOL in
studies of people with ESRD treated by
dialysis?
Subquestion 4c: How have
instruments used to measure QOL in
studies of people with ESRD treated by
dialysis been validated?
Subquestion 4d: What is the impact of
placebo effect in studies used to
measure QOL in people with ESRD
treated by dialysis and what study
designs are needed to mitigate the
impact?
PICOTS (Populations, Interventions,
Comparators, Outcomes, Timing,
Settings)
Population(s)
• All KQs: US ESRD Medicare
population (non-institutionalized)
• KQ 1: Adults and children with ESRD
on hemodialysis (no age restriction)
• KQs 2 and 3: Adults and children
with ESRD on hemodialysis
• KQ 4: Adults and children with ESRD
treated with any dialysis or other nontransplant treatment
jbell on DSK3GLQ082PROD with NOTICES
Interventions
• KQ 1: Different frequency or duration
of hemodialysis
• KQ 2: More frequent hemodialysis (3
versus > 3 sessions/week)
• KQ 3: Increased duration of
hemodialysis sessions (12 hours
versus > 12 hours per week; or
daytime versus night time)
• KQ 4: For this question, we will
include studies of QOL in people with
ESRD receiving any type of dialysis.
• We will abstract data on all home
hemodialysis machines (2008K@
Home Hemodialysis Machines,
NxStage® System One, NxStage®
System S) as well as all devices used
in-center (a large variety of machines
VerDate Sep<11>2014
17:47 Jun 19, 2019
Jkt 247001
used in center exist and all will be
considered for data collection)
Comparators (see Table 1)
• KQs 1 and 4: Usual care (3 times per
week and 3–4 hours per treatment)
• KQ 2: More frequent hemodialysis (>3
session/week); usual care
• KQ 3: Increased duration of
hemodialysis sessions (> 12 hours per
week, or nocturnal, overnight); usual
care
Outcomes
• KQ 1: Not applicable (see Appendix A
for a list of the patient
characteristics that will be
considered for this KQ)
• KQs 2 and 3:
Æ Final health outcomes (see
Appendix B for a detailed list of
outcomes): Clinical outcomes
including cardiovascular events,
hospitalizations, QOL, pregnancy
outcomes, and mortality
Æ Adverse events (see Appendix B for
a detailed list of outcomes):
Intradialytic hypotension, access
complications, loss of residual
kidney function, infectious events,
myocardial stunning
hospitalizations, and patient and
caregiver burden
Æ Intermediate outcomes (see
Appendix B for a detailed list of
outcomes): Metabolic/inflammatory
control, blood pressure control,
dialysis recovery time
• KQ 4:
Æ Instruments used to measure QOL
in dialysis patients
Æ Psychometric properties of these
instruments
Æ Minimal clinically important
difference for these instruments
Æ Validation of these instruments
Æ Placebo effect in studies of QOL in
dialysis patients and what study
designs are needed to mitigate the
impact
Timing
• KQs 1–3: Minimum of 6 months of
follow-up after the intervention is
initiated
• KQ 4: No minimum follow-up
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
Setting
• Home dialysis, and dialysis center
(Non Institutionalized)
Virginia Mackay-Smith,
Associate Director, Office of the Director,
AHRQ.
[FR Doc. 2019–12650 Filed 6–19–19; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–19–16JO]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Pregnancy Risk
Assessment Monitoring System
(PRAMS) to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on August
31, 2018 to obtain comments from the
public and affected agencies. CDC
received four comments related to the
previous notice, two non-substantive,
two in support of the data collection; no
modifications were made to the PRAMS
plan in response to comments. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
E:\FR\FM\20JNN1.SGM
20JNN1
28818
Federal Register / Vol. 84, No. 119 / Thursday, June 20, 2019 / Notices
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
The Pregnancy Risk Assessment
Monitoring System (PRAMS)—Existing
Collection in Use without an OMB
Control Number—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
jbell on DSK3GLQ082PROD with NOTICES
Background and Brief Description
The Pregnancy Risk Assessment
Monitoring System (PRAMS) is a
surveillance project of the Centers for
Disease Control and Prevention (CDC)
and state health departments.
Developed in 1987, PRAMS collects
state-specific, population-based data on
maternal attitudes and experiences
before, during, and shortly after
pregnancy. The Centers for Disease
Control and Prevention (CDC) seeks
OMB approval to collect information
through the Pregnancy Risk Assessment
Monitoring System (PRAMS) for three
years.
PRAMS provides data not available
from other sources. These data can be
used to identify groups of women and
infants at high risk for health problems,
to monitor changes in health status, and
to measure progress towards goals in
improving the health of mothers and
infants. PRAMS data are used by
researchers to investigate emerging
issues in the field of reproductive health
and by federal, state and local
governments to plan and review
programs and policies aimed at
VerDate Sep<11>2014
17:47 Jun 19, 2019
Jkt 247001
reducing health problems among
mothers and babies.
PRAMS is a state customized survey
conducted in 51 sites and covers 83%
of all live births in the United States.
Information is collected by 2–6 months
after live birth or stillbirth by mail
survey with telephone follow-up for
non-responders. In addition, call back
surveys may be implemented as a follow
up to the initial survey to gather
additional information on postpregnancy experiences and infant and
toddler health. Because PRAMS uses
standardized data collection methods, it
allows data to be compared among
states. States can implement the survey
on an ongoing basis or as a point-in-time
survey. In participating states, a sample
of women who have recently given birth
to a live born or stillborn infant is
selected from birth certificates or fetal
death files. The sample is stratified
based on the state’s population of
interest to ensure high-risk populations
are adequately represented in the data.
The PRAMS survey instrument for
live births is based on a core set of
questions common across all states that
remain the same for each three-year
phase of data collection. PRAMS is
currently in Phase 8, which began in
2016. In addition, CDC provides
optional standardized modules (pregrouped questions on a select topic) that
states may use to customize survey
content at the beginning of each phase
of data collection. For each state, the
time for a respondent with a recent live
birth to complete the core and selected
standard module questions does not
exceed 35 minutes in length. Topics for
both the core and standard modules
include health conditions (which
includes chronic conditions such as
diabetes, hypertension, mental health,
oral health, cancer, as well as
pregnancy-induced health conditions
and family history of select conditions);
health behaviors (including tobacco and
alcohol use, substance use [licit and
illicit], injury prevention and safety,
nutrition, and physical activity); health
care services (such as preconception
care, prenatal care, postpartum care,
contraceptive care, vaccinations, access
to care and insurance coverage, receipt
of recommended services and provider
counseling received); infant health and
development; infant care practices (such
as breastfeeding, safe sleep practices);
social services received (such as WIC or
home visiting); the social context of
child bearing (such as intimate partner
violence, social support, adverse
childhood experiences, stressful life
experiences and racism); attitudes and
feeling about the pregnancy including
pregnancy intentions.
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
At times, states may also be funded to
address emerging topics of interest with
supplemental modules (pre-grouped
questions on a select topic). These
supplemental modules address national
and state-specific priorities and are
typically fielded for one year. In the
recent past, they have been used to
address pandemic influenza H1N1
(2009), electronic cigarettes (2014),
marijuana (2016), Zika (2017), and
emergency preparedness and response
as they impact pregnancy (2017).
Supplemental modules planned for
collection for 2019 births will include
family history of breast and ovarian
cancer, disabilities and prescription and
illicit opioid use. Additional
supplemental modules (estimated
respondents and burden the same each
year) may be developed to address other
emergent issues as they arise, such as
paternal involvement, emerging
infectious diseases, environmental
disasters, and other public health
problems affecting women of
reproductive age and their pregnancies.
The estimated time for a respondent to
complete supplemental modules is five
minutes. Because PRAMS infrastructure
was developed to access a specific and
vulnerable subpopulation, the PRAMS
infrastructure can be rapidly adapted for
targeted information collection that
would not be feasible with other
surveillance methods.
PRAMS can also be adapted to do call
back surveys. Women who respond to
the PRAMS survey may be re-contacted
(opt-out consent process used) later
(approximately nine months post-birth)
to collect additional information about
post-pregnancy experiences and infant
and toddler health. The currently
planned call back survey will be
targeted to areas with a high burden of
opioid overdose deaths and include
topics such as opioid misuse and access
to medication assisted therapy,
experiences with respectful care,
postpartum care, rapid repeat
pregnancy, infant feeding practices,
infant health and social services such as
well child visit attendance, home
visitation, developmental delays, and
social supports. The time for a
respondent to complete the call back
survey is 30 minutes. Additional call
back surveys (estimated burden
assumed the same each year) may be
developed to address other emergent
issues as they arise.
The stillbirth survey, administered in
the state of Utah only at this current
time, only includes a core survey
instrument. Total time estimated for
women with a recent stillbirth
completing the survey, inclusive of
informed consent is 25 minutes.
E:\FR\FM\20JNN1.SGM
20JNN1
28819
Federal Register / Vol. 84, No. 119 / Thursday, June 20, 2019 / Notices
As part of the questionnaire
development process, field testing will
be conducted prior to implementation of
new supplemental modules and call
back surveys, as well as new or
substantively revised questions for the
core module prior to a new phase. Field
testing will be conducted among women
with infants one year or younger in
health clinics to identify issues that may
affect implementation or quality of the
data collected. Field testing will only be
conducted for new or substantively
changed questions. Total time estimated
to complete the field testing process
inclusive of verbal consent, survey
administration and debriefing questions
is approximately 20 minutes.
The burden estimate for PRAMS
includes five types of information
collection: (1) Information collection
associated with the PRAMS data
collection for women with recent live
births (PRAMS core questions and state-
selected standard modules); (2)
supplemental modules for emerging
issues; (3) call back surveys; (4) PRAMS
data collection for women with recent
stillbirths; and (5) PRAMS field testing
data collection to inform questionnaire
development. Participation is voluntary
and there are no costs to respondents
other than their time. The total
estimated annualized burden hours are
29,765.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Women who recently delivered a live birth ....
PRAMS Phase 8 (Core Questions plus state
selected standard modules).
Supplemental modules ...................................
Call Back Surveys ..........................................
Field Testing ...................................................
PRAMS Stillbirth Questionnaire .....................
Women who recently delivered a still birth .....
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–13053 Filed 6–19–19; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
[60Day–19–19BDE; Docket No. CDC–2019–
0051]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Maternal Mortality Review
Information Application (MMRIA).
MMRIA is a standardized data
collection system that allows Maternal
Mortality Review Committees (MMRCs)
SUMMARY:
VerDate Sep<11>2014
17:47 Jun 19, 2019
Jkt 247001
to abstract relevant data from a variety
of sources, document committee
decisions, and analyze data to better
understand the contributing factors and
preventability of maternal deaths in
order to develop recommendations for
prevention.
CDC must receive written
comments on or before August 19, 2019.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2019–
0051 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
DATES:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
jbell on DSK3GLQ082PROD with NOTICES
Number of
respondents
Type of respondent
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
52,076
1
26/60
61,230
3,961
150
160
1
1
1
1
5/60
30/60
20/60
25/60
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
E:\FR\FM\20JNN1.SGM
20JNN1
]]>Agencies
[Federal Register Volume 84, Number 119 (Thursday, June 20, 2019)]
[Notices]
[Pages 28817-28819]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-13053]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-19-16JO]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Pregnancy Risk Assessment Monitoring System
(PRAMS) to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on August 31,
2018 to obtain comments from the public and affected agencies. CDC
received four comments related to the previous notice, two non-
substantive, two in support of the data collection; no modifications
were made to the PRAMS plan in response to comments. This notice serves
to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information,
[[Page 28818]]
including the validity of the methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
The Pregnancy Risk Assessment Monitoring System (PRAMS)--Existing
Collection in Use without an OMB Control Number--National Center for
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Pregnancy Risk Assessment Monitoring System (PRAMS) is a
surveillance project of the Centers for Disease Control and Prevention
(CDC) and state health departments. Developed in 1987, PRAMS collects
state-specific, population-based data on maternal attitudes and
experiences before, during, and shortly after pregnancy. The Centers
for Disease Control and Prevention (CDC) seeks OMB approval to collect
information through the Pregnancy Risk Assessment Monitoring System
(PRAMS) for three years.
PRAMS provides data not available from other sources. These data
can be used to identify groups of women and infants at high risk for
health problems, to monitor changes in health status, and to measure
progress towards goals in improving the health of mothers and infants.
PRAMS data are used by researchers to investigate emerging issues in
the field of reproductive health and by federal, state and local
governments to plan and review programs and policies aimed at reducing
health problems among mothers and babies.
PRAMS is a state customized survey conducted in 51 sites and covers
83% of all live births in the United States. Information is collected
by 2-6 months after live birth or stillbirth by mail survey with
telephone follow-up for non-responders. In addition, call back surveys
may be implemented as a follow up to the initial survey to gather
additional information on post-pregnancy experiences and infant and
toddler health. Because PRAMS uses standardized data collection
methods, it allows data to be compared among states. States can
implement the survey on an ongoing basis or as a point-in-time survey.
In participating states, a sample of women who have recently given
birth to a live born or stillborn infant is selected from birth
certificates or fetal death files. The sample is stratified based on
the state's population of interest to ensure high-risk populations are
adequately represented in the data.
The PRAMS survey instrument for live births is based on a core set
of questions common across all states that remain the same for each
three-year phase of data collection. PRAMS is currently in Phase 8,
which began in 2016. In addition, CDC provides optional standardized
modules (pre-grouped questions on a select topic) that states may use
to customize survey content at the beginning of each phase of data
collection. For each state, the time for a respondent with a recent
live birth to complete the core and selected standard module questions
does not exceed 35 minutes in length. Topics for both the core and
standard modules include health conditions (which includes chronic
conditions such as diabetes, hypertension, mental health, oral health,
cancer, as well as pregnancy-induced health conditions and family
history of select conditions); health behaviors (including tobacco and
alcohol use, substance use [licit and illicit], injury prevention and
safety, nutrition, and physical activity); health care services (such
as preconception care, prenatal care, postpartum care, contraceptive
care, vaccinations, access to care and insurance coverage, receipt of
recommended services and provider counseling received); infant health
and development; infant care practices (such as breastfeeding, safe
sleep practices); social services received (such as WIC or home
visiting); the social context of child bearing (such as intimate
partner violence, social support, adverse childhood experiences,
stressful life experiences and racism); attitudes and feeling about the
pregnancy including pregnancy intentions.
At times, states may also be funded to address emerging topics of
interest with supplemental modules (pre-grouped questions on a select
topic). These supplemental modules address national and state-specific
priorities and are typically fielded for one year. In the recent past,
they have been used to address pandemic influenza H1N1 (2009),
electronic cigarettes (2014), marijuana (2016), Zika (2017), and
emergency preparedness and response as they impact pregnancy (2017).
Supplemental modules planned for collection for 2019 births will
include family history of breast and ovarian cancer, disabilities and
prescription and illicit opioid use. Additional supplemental modules
(estimated respondents and burden the same each year) may be developed
to address other emergent issues as they arise, such as paternal
involvement, emerging infectious diseases, environmental disasters, and
other public health problems affecting women of reproductive age and
their pregnancies. The estimated time for a respondent to complete
supplemental modules is five minutes. Because PRAMS infrastructure was
developed to access a specific and vulnerable subpopulation, the PRAMS
infrastructure can be rapidly adapted for targeted information
collection that would not be feasible with other surveillance methods.
PRAMS can also be adapted to do call back surveys. Women who
respond to the PRAMS survey may be re-contacted (opt-out consent
process used) later (approximately nine months post-birth) to collect
additional information about post-pregnancy experiences and infant and
toddler health. The currently planned call back survey will be targeted
to areas with a high burden of opioid overdose deaths and include
topics such as opioid misuse and access to medication assisted therapy,
experiences with respectful care, postpartum care, rapid repeat
pregnancy, infant feeding practices, infant health and social services
such as well child visit attendance, home visitation, developmental
delays, and social supports. The time for a respondent to complete the
call back survey is 30 minutes. Additional call back surveys (estimated
burden assumed the same each year) may be developed to address other
emergent issues as they arise.
The stillbirth survey, administered in the state of Utah only at
this current time, only includes a core survey instrument. Total time
estimated for women with a recent stillbirth completing the survey,
inclusive of informed consent is 25 minutes.
[[Page 28819]]
As part of the questionnaire development process, field testing
will be conducted prior to implementation of new supplemental modules
and call back surveys, as well as new or substantively revised
questions for the core module prior to a new phase. Field testing will
be conducted among women with infants one year or younger in health
clinics to identify issues that may affect implementation or quality of
the data collected. Field testing will only be conducted for new or
substantively changed questions. Total time estimated to complete the
field testing process inclusive of verbal consent, survey
administration and debriefing questions is approximately 20 minutes.
The burden estimate for PRAMS includes five types of information
collection: (1) Information collection associated with the PRAMS data
collection for women with recent live births (PRAMS core questions and
state-selected standard modules); (2) supplemental modules for emerging
issues; (3) call back surveys; (4) PRAMS data collection for women with
recent stillbirths; and (5) PRAMS field testing data collection to
inform questionnaire development. Participation is voluntary and there
are no costs to respondents other than their time. The total estimated
annualized burden hours are 29,765.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Women who recently delivered a live PRAMS Phase 8 (Core 52,076 1 26/60
birth. Questions plus state
selected standard
modules).
Supplemental modules.... 61,230 1 5/60
Call Back Surveys....... 3,961 1 30/60
Field Testing........... 150 1 20/60
Women who recently delivered a still PRAMS Stillbirth 160 1 25/60
birth. Questionnaire.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-13053 Filed 6-19-19; 8:45 am]
BILLING CODE 4163-18-P
